• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hydroxychloroquine-induced hypoglycaemia in non-diabetic renal patient on peritoneal dialysis.羟氯喹引起接受腹膜透析的非糖尿病肾病患者低血糖症。
BMJ Case Rep. 2018 Apr 18;2018:bcr-2017-223639. doi: 10.1136/bcr-2017-223639.
2
Hydroxychloroquine in systemic lupus erythematosus (SLE).羟氯喹在系统性红斑狼疮(SLE)中的应用。
Expert Opin Drug Saf. 2017 Mar;16(3):411-419. doi: 10.1080/14740338.2017.1269168. Epub 2016 Dec 14.
3
Systemic lupus erythematosus and hydroxychloroquine-related acute intermittent porphyria.系统性红斑狼疮与羟氯喹相关的急性间歇性卟啉病。
Rheumatol Int. 2020 May;40(5):777-783. doi: 10.1007/s00296-019-04500-8. Epub 2019 Dec 21.
4
The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients.肥胖对狼疮肾炎患者羟氯喹血药浓度的影响。
Lupus. 2021 Apr;30(4):554-559. doi: 10.1177/0961203320985214. Epub 2021 Jan 5.
5
Early cutaneous eruptions after oral hydroxychloroquine in a lupus erythematosus patient: A case report and review of the published work.红斑狼疮患者口服羟氯喹后早期皮肤疹:病例报告及文献复习。
J Dermatol. 2018 Mar;45(3):344-348. doi: 10.1111/1346-8138.14156. Epub 2017 Dec 14.
6
Cumulative dose of hydroxychloroquine is associated with a decrease of resting heart rate in patients with systemic lupus erythematosus: a pilot study.羟氯喹累积剂量与系统性红斑狼疮患者静息心率降低相关:一项初步研究。
Lupus. 2015 Oct;24(11):1204-9. doi: 10.1177/0961203315580870. Epub 2015 Apr 6.
7
Simple dose-escalation regimen for hydroxychloroquine-induced hypersensitivity reaction in patients with systemic lupus erythematosus enabled treatment resumption.简单的羟氯喹诱导的系统性红斑狼疮患者过敏反应剂量递增方案可使治疗得以恢复。
Lupus. 2019 Oct;28(12):1473-1476. doi: 10.1177/0961203319879987. Epub 2019 Oct 1.
8
Hydroxychloroquine-induced phospholipidosis in a case of SLE: the wolf in zebra clothing.系统性红斑狼疮患者中羟氯喹诱发的磷脂沉积症:披着斑马皮的狼。
Ultrastruct Pathol. 2013 Apr;37(2):146-50. doi: 10.3109/01913123.2012.751950.
9
Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study.羟氯喹对系统性红斑狼疮孕妇早产及胎儿生长受限的影响:一项描述性队列研究
Lupus. 2015 Nov;24(13):1384-91. doi: 10.1177/0961203315591027. Epub 2015 Jun 16.
10
Hydroxychloroquine desensitization, an effective method to overcome hypersensitivity-a multicenter experience.羟氯喹脱敏,一种克服超敏反应的有效方法——多中心经验
Lupus. 2018 Apr;27(5):703-707. doi: 10.1177/0961203317735185. Epub 2017 Oct 9.

引用本文的文献

1
Association between hydroxychloroquine use and risk of diabetes mellitus in systemic lupus erythematosus and rheumatoid arthritis: a UK Biobank-based study.羟氯喹的使用与系统性红斑狼疮和类风湿关节炎患者糖尿病发病风险的相关性:基于英国生物库的研究。
Front Endocrinol (Lausanne). 2024 Nov 6;15:1381321. doi: 10.3389/fendo.2024.1381321. eCollection 2024.
2
Physiologically-Based Pharmacokinetics Modeling for Hydroxychloroquine as a Treatment for Malaria and Optimized Dosing Regimens for Different Populations.基于生理的羟氯喹啉治疗疟疾的药代动力学建模及不同人群的优化给药方案
J Pers Med. 2022 May 14;12(5):796. doi: 10.3390/jpm12050796.
3
Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge.羟氯喹在系统性红斑狼疮中的应用:当前知识概述
Ther Adv Musculoskelet Dis. 2022 Feb 14;14:1759720X211073001. doi: 10.1177/1759720X211073001. eCollection 2022.
4
System for administering and monitoring hydroxychloroquine prophylaxis for COVID-19 in accordance with a national advisory: preliminary experience of a tertiary care institute in India.根据国家建议实施和监测羟氯喹预防新冠病毒病的系统:印度一家三级医疗机构的初步经验
Expert Rev Anti Infect Ther. 2021 Oct;19(10):1331-1339. doi: 10.1080/14787210.2021.1909476. Epub 2021 Apr 15.
5
[Not Available].[无可用内容]。
CMAJ. 2020 Oct 13;192(41):E1242-E1246. doi: 10.1503/cmaj.200528-f.
6
Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?抗冠状病毒药物:治疗新型冠状病毒肺炎(SARS-CoV-2)的候选药物?
Front Microbiol. 2020 Aug 13;11:1818. doi: 10.3389/fmicb.2020.01818. eCollection 2020.
7
Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection.COVID-19 感染期间血液透析患者对羟氯喹和阿奇霉素的耐受性。
Nephrol Dial Transplant. 2020 Aug 1;35(8):1346-1353. doi: 10.1093/ndt/gfaa191.
8
Current coronavirus (SARS-CoV-2) epidemiological, diagnostic and therapeutic approaches: An updated review until June 2020.当前冠状病毒(SARS-CoV-2)的流行病学、诊断和治疗方法:截至2020年6月的最新综述
EXCLI J. 2020 Jul 20;19:992-1016. doi: 10.17179/excli2020-2554. eCollection 2020.
9
Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID-19 pandemic.羟氯喹在糖尿病患者中的降血糖作用:COVID-19 大流行时期的风险和获益。
J Diabetes. 2020 Sep;12(9):659-667. doi: 10.1111/1753-0407.13053. Epub 2020 Jun 11.
10
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.氯喹、羟氯喹和阿奇霉素用于治疗新型冠状病毒肺炎(SARS-CoV-2感染)时的安全性考量
CMAJ. 2020 Apr 27;192(17):E450-E453. doi: 10.1503/cmaj.200528. Epub 2020 Apr 8.

本文引用的文献

1
Hydroxychloroquine in patients with systemic lupus erythematosus with end-stage renal disease.羟氯喹在患有终末期肾病的系统性红斑狼疮患者中的应用。
J Investig Med. 2016 Apr;64(4):908-10. doi: 10.1136/jim-2016-000065. Epub 2016 Feb 19.
2
Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence.系统性红斑狼疮患者的羟氯喹血药浓度:阐明给药争议并提高依从性
J Rheumatol. 2015 Nov;42(11):2092-7. doi: 10.3899/jrheum.150379. Epub 2015 Oct 1.
3
Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.羟氯喹以剂量依赖方式降低狼疮患者新发糖尿病的风险:一项基于人群的队列研究。
Rheumatology (Oxford). 2015 Jul;54(7):1244-9. doi: 10.1093/rheumatology/keu451. Epub 2015 Jan 12.
4
Hydroxychloroquine as a glucose lowering drug.羟氯喹作为一种降糖药物。
BMJ Case Rep. 2011 Oct 28;2011:bcr0620114393. doi: 10.1136/bcr.06.2011.4393.
5
Hydroxychloroquine: a diabetic drug in disguise?羟氯喹:一种伪装成糖尿病药物的药物?
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.08.2008.0654. Epub 2009 Mar 2.
6
Hypoglycemia induced by hydroxychloroquine in a patient treated for rheumatoid arthritis.类风湿关节炎患者使用羟氯喹引发低血糖症。
J Clin Rheumatol. 2011 Jan;17(1):46-7. doi: 10.1097/RHU.0b013e3182098e1f.
7
Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.羟氯喹与类风湿关节炎和系统性红斑狼疮女性患者的血糖。
J Rheumatol. 2010 Jun;37(6):1136-42. doi: 10.3899/jrheum.090994. Epub 2010 May 1.
8
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review.抗疟药物治疗系统性红斑狼疮的临床疗效和副作用:系统评价。
Ann Rheum Dis. 2010 Jan;69(1):20-8. doi: 10.1136/ard.2008.101766.
9
Hypoglycaemia induced by hydroxychloroquine in a non-diabetic patient treated for RA.羟氯喹在一名接受类风湿关节炎治疗的非糖尿病患者中诱发低血糖症。
Rheumatology (Oxford). 2008 Mar;47(3):378-9. doi: 10.1093/rheumatology/kem378. Epub 2008 Jan 25.
10
Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis.羟氯喹与类风湿关节炎患者的糖尿病风险
JAMA. 2007 Jul 11;298(2):187-93. doi: 10.1001/jama.298.2.187.

羟氯喹引起接受腹膜透析的非糖尿病肾病患者低血糖症。

Hydroxychloroquine-induced hypoglycaemia in non-diabetic renal patient on peritoneal dialysis.

作者信息

El-Solia Ahmed, Al-Otaibi Khalid, Ai-Hwiesh Abdullah K

机构信息

Renal Department, Southend University Hospital NHS Foundation Trust, Westcliff-on-Sea, Essex, UK.

Urology Department, Abdulrahman Bin Faisal University, King Fahd Hospital of the University, Dammam, Saudi Arabia.

出版信息

BMJ Case Rep. 2018 Apr 18;2018:bcr-2017-223639. doi: 10.1136/bcr-2017-223639.

DOI:10.1136/bcr-2017-223639
PMID:29669768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5911099/
Abstract

Hydroxychloroquine (HCQ) is a commonly used drug for the treatment of systemic lupus erythematosus (SLE). Renal involvement is common in SLE. We present a 25-year-old woman with lupus nephritis on peritoneal dialysis whose lupus was quite silent for almost three years, and secondary to HCQ she developed severe hypoglycaemic episodes, which were completely resolved after stopping HCQ.

摘要

羟氯喹啉(HCQ)是一种常用于治疗系统性红斑狼疮(SLE)的药物。肾脏受累在SLE中很常见。我们报告一名25岁患有狼疮性肾炎且正在接受腹膜透析的女性,其狼疮病情几乎隐匿了三年,继发于HCQ后,她出现了严重的低血糖发作,停用HCQ后低血糖发作完全缓解。